Avalon Investment & Advisory’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,141
| Closed | -$247K | – | 337 |
|
|
2021
Q4 | $247K | Sell |
18,141
-8,262
| -31% | -$112K | 0.01% | 287 |
|
|
2021
Q3 | $432K | Sell |
26,403
-3,579
| -12% | -$58.6K | 0.01% | 288 |
|
|
2021
Q2 | $505K | Sell |
29,982
-7,977
| -21% | -$134K | 0.01% | 280 |
|
|
2021
Q1 | $693K | Sell |
37,959
-111,902
| -75% | -$2.04M | 0.02% | 262 |
|
|
2020
Q4 | $2.73M | Buy |
149,861
+1,254
| +0.8% | +$22.8K | 0.06% | 184 |
|
|
2020
Q3 | $2.65M | Sell |
148,607
-45,006
| -23% | -$803K | 0.06% | 164 |
|
|
2020
Q2 | $3.47M | Sell |
193,613
-40,227
| -17% | -$721K | 0.08% | 143 |
|
|
2020
Q1 | $3.55M | Buy |
233,840
+106,411
| +84% | +$1.62M | 0.09% | 150 |
|
|
2019
Q4 | $2.51M | Buy |
+127,429
| New | +$2.51M | 0.05% | 196 |
|
|
2019
Q2 | – | Sell |
-58,089
| Closed | -$1.18M | – | 346 |
|
|
2019
Q1 | $1.18M | Buy |
+58,089
| New | +$1.18M | 0.03% | 241 |
|